Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models
2015 ◽
Vol 3
(5)
◽
pp. 987-994
◽
2017 ◽
Vol 20
(2)
◽
pp. 212-220
◽
2020 ◽
Vol 16
(8)
◽
pp. 128
2011 ◽
Vol 62
(1)
◽
pp. 221-228
◽